Qilian International Holding Group Limited (QLI)
After hours:
- PR Newswire
Qilian International plans to adjust industrial investment
Qilian International Holdings Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a pharmaceutical and chemical products manufacturer headquartered in China, today announced: In the past two years, Qilian International Holdings Group Limited has encountered significant challenges stemming from the continuous shrinkage in market demand for its oxytetracycline products, coupled with a persistent decline in market prices and escalating environmental protection standards. These factors have col
- PR Newswire
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that on January 10, 2024, the Company received a written notification from the Nasdaq's Listing Qualifications Department, granting the Company another 180 calendar days extension, or until July 8, 2024, to regain compliance with Nasdaq's minimum bid price requirement.
- Simply Wall St.
Qilian International Holding Group First Half 2023 Earnings: EPS: US$0.014 (vs US$0.002 in 1H 2022)
Qilian International Holding Group ( NASDAQ:QLI ) First Half 2023 Results Key Financial Results Revenue: US$29.2m (down...
